Vaccine effectiveness of recombinant and standard dose influenza vaccines against outpatient illness during 2018–2019 and 2019–2020 calculated using a retrospective test-negative design

Newer influenza vaccine formulations have entered the market, but real-world effectiveness studies are not widely conducted until there is sufficient uptake. We conducted a retrospective test-negative case-control study to determine relative vaccine effectiveness (rVE) of recombinant influenza vacci...

Descripción completa

Detalles Bibliográficos
Autores principales: Zimmerman, Richard K., Dauer, Klancie, Clarke, Lloyd, Nowalk, Mary Patricia, Raviotta, Jonathan M., Balasubramani, G. K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Influenza
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026862/
https://www.ncbi.nlm.nih.gov/pubmed/36809982
http://dx.doi.org/10.1080/21645515.2023.2177461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026862/
https://www.ncbi.nlm.nih.gov/pubmed/36809982
http://dx.doi.org/10.1080/21645515.2023.2177461

Ejemplares similares